Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Colorectal

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 1 · 50%

Overall survival · people with metastatic colorectal cancer ‐ extended RAS WT

The intervention leads to lower overall survival (high certainty).

1 finding from 1 review

Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
HR 0.77 [0.67, 0.88]
4 studies · 1053 participants
High

Overall survival · people with metastatic colorectal cancer ‐ extended RAS MT

The intervention showed no clear difference in overall survival (moderate certainty).

1 finding from 1 review

Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 2017 · Cochrane Headline outcomes only
HR 1.09 [0.93, 1.28]
4 studies · 1768 participants
Moderate